{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:53:00Z","timestamp":1780620780181,"version":"3.54.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2017,9,4]],"date-time":"2017-09-04T00:00:00Z","timestamp":1504483200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,9,4]],"date-time":"2017-09-04T00:00:00Z","timestamp":1504483200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1038\/bmt.2017.178","type":"journal-article","created":{"date-parts":[[2017,9,4]],"date-time":"2017-09-04T13:41:02Z","timestamp":1504532462000},"page":"1549-1555","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Outcomes following autologous hematopoietic stem cell transplant for patients with relapsed Wilms\u2019 tumor: a CIBMTR retrospective analysis"],"prefix":"10.1038","volume":"52","author":[{"given":"M H","family":"Malogolowkin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M T","family":"Hemmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Le-Rademacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G A","family":"Hale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P A","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A R","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Kitko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Abdel-Azim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Dandoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Angel Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R P","family":"Gale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Guilcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Jodele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K A","family":"Kasow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M L","family":"MacMillian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Thakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B M","family":"Wirk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Woolfrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E L","family":"Thiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,4]]},"reference":[{"key":"BFbmt2017178_CR1","volume-title":"Renal Tumors. Principles and Practice of Pediatric Oncology","author":"C Fernandez","year":"2011","unstructured":"Fernandez C, Geller JI, Ehrlich PF, Hill DA, Kalapurakal JA, Grundy PE et al. Renal Tumors. Principles and Practice of Pediatric Oncology. In: Pizzo PA, Poplack DG ( eds). Lippincott Williams and Wilkins: Philadelphia, PA, USA, 2011."},{"key":"BFbmt2017178_CR2","unstructured":"Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF et al. SEER Cancer Statistics Review, 1975-2012, National Cancer Institute, based on November 2014 SEER data submission, posted to the SEER web site, April 2015. Available at http:\/\/seer.cancer.gov\/csr\/1975_2012\/results_merged\/sect_29_childhood_cancer_iccc.pdf. Accessed on 6 December 2015."},{"key":"BFbmt2017178_CR3","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1200\/JCO.1989.7.5.638","volume":"7","author":"P Grundy","year":"1989","unstructured":"Grundy P, Breslow N, Green DM, Sharples K, Evans A, D'Angio GJ . Prognostic factors for children with recurrent Wilms' tumor: results from the Second and Third National Wilms' Tumor Study. J Clin Oncol 1989; 7: 638\u2013647.","journal-title":"J Clin Oncol"},{"key":"BFbmt2017178_CR4","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/1097-0142(19910201)67:3<567::AID-CNCR2820670307>3.0.CO;2-2","volume":"67","author":"CR Pinkerton","year":"1991","unstructured":"Pinkerton CR, Groot-Loonen JJ, Morris-Jones PH, Pritchard J . Response rates in relapsed Wilms' tumor. A need for new effective agents. Cancer 1991; 67: 567\u2013571.","journal-title":"Cancer"},{"key":"BFbmt2017178_CR5","first-page":"170","volume":"33","author":"F Pein","year":"1999","unstructured":"Pein F, Rey A, de Kraker J . Multivariate analysis of adverse prognostic factors (APF) in children with recurrent (Rec) Wilms' tumor (WT) after initial treatment according to SIOP-6 or SIOP-9 strategies. Med Pediatr Oncol 1999; 33: 170.","journal-title":"Med Pediatr Oncol"},{"key":"BFbmt2017178_CR6","unstructured":"Tannous R, Giller R, Holmes E Intensive therapy for high risk (HR) relapsed Wilms' tumor (WT). A CCG-4921\/POG-9445 Study Report. In: Proceeding of ASCO 200; 588a abstract 2315."},{"key":"BFbmt2017178_CR7","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1097\/00043426-200203000-00007","volume":"24","author":"JS Dome","year":"2002","unstructured":"Dome JS, Liu T, Krasin M, Lott L, Shearer P, Daw NC et al. Improved survival for patients with recurrent Wilms tumor: the experience at St. Jude Children's Research Hospital. J Pediatr Hematol Oncol 2002; 24: 192\u2013198.","journal-title":"J Pediatr Hematol Oncol"},{"key":"BFbmt2017178_CR8","first-page":"463","volume":"20","author":"H Reinhard","year":"2008","unstructured":"Reinhard H, Schmidt A, Furtwangler R, Leuschner I, Rube C, Von Schweinitz D et al. Outcome of relapses of nephroblastoma in patients registered in the SIOP\/GPOH trials and studies. Oncol 2008; 20: 463\u2013467.","journal-title":"Oncol"},{"key":"BFbmt2017178_CR9","unstructured":"Hale J, Hobson R, Moroz V, Satori P Results of UK Children's Cancer and Leukemia Group (CCLG) protocol for relapsed Wilms tumor (UKWR): Unified relapse strategy improves outcome. In: 40th meeting of International Society of Paediatric Oncology 2008; pp 62."},{"key":"BFbmt2017178_CR10","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1002\/pbc.20822","volume":"48","author":"DM Green","year":"2007","unstructured":"Green DM, Cotton CA, Malogolowkin M, Breslow NE, Perlman E, Miser J et al. Treatment of Wilms tumor relapsing after initial treatment with vincristine and actinomycin D: a report from the National Wilms Tumor Study Group. Pediatr Blood Cancer 2007; 48: 493\u2013499.","journal-title":"Pediatr Blood Cancer"},{"key":"BFbmt2017178_CR11","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/pbc.21267","volume":"50","author":"M Malogolowkin","year":"2008","unstructured":"Malogolowkin M, Cotton CA, Green DM, Breskiw NE, Perlman E, Miser J et al. Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. a report from the National Wilms Tumor Study Group. Pediatr Blood Cancer 2008; 50: 236\u2013241.","journal-title":"Pediatr Blood Cancer"},{"key":"BFbmt2017178_CR12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/mpo.2950220103","volume":"22","author":"A Garaventa","year":"1994","unstructured":"Garaventa A, Hartmann O, Bernard JL, Zucker JM, Pardo N, Castel V et al. Autologous bone marrow transplantation for pediatric Wilms' tumor: the experience of the European Bone Marrow Transplantation Solid Tumor Registry. Med Pediatr Oncol 1994; 22: 11\u201314.","journal-title":"Med Pediatr Oncol"},{"key":"BFbmt2017178_CR13","doi-asserted-by":"publisher","first-page":"3295","DOI":"10.1200\/JCO.1998.16.10.3295","volume":"16","author":"F Pein","year":"1998","unstructured":"Pein F, Michon J, Valteau-Couanet D, Quintana E, Frappaz D, Vannier JP et al. High-dose melphalan, etoposide, and carboplatin followed by autologous stem-cell rescue in pediatric high-risk recurrent Wilms' tumor: a French Society of Pediatric Oncology study. J Clin Oncol 1998; 16: 3295\u20133301.","journal-title":"J Clin Oncol"},{"key":"BFbmt2017178_CR14","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1038\/sj.bmt.1703771","volume":"30","author":"B Kremens","year":"2002","unstructured":"Kremens B, Gruhn B, Klingebiel T, Hasan C, Laws HJ, Koscielniak E et al. High-dose chemotherapy with autologous stem cell rescue in children with nephroblastoma. Bone Marrow Transplant 2002; 30: 893\u2013898.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2017178_CR15","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1200\/JCO.2004.09.073","volume":"22","author":"AD Campbell","year":"2008","unstructured":"Campbell AD, Cohn SL, Reynolds M, Seshadri R, Morgan E, Geissler G et al. Treatment of relapsed Wilms' tumor with high-dose therapy and autologous hematopoietic stem-cell rescue: the experience at Children's Memorial Hospital. J Clin Oncol 2008; 22: 2885\u20132890.","journal-title":"J Clin Oncol"},{"key":"BFbmt2017178_CR16","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/pbc.21524","volume":"51","author":"F Spreafico","year":"2008","unstructured":"Spreafico F, Bisogno G, Collini P, Jankner A, Gandola L, D\u2019Angelo P et al. Treatment of high-risk relapsed Wilms tumor with dose-intensive chemotherapy, marrow-ablative chemotherapy, and autologous hematopoietic stem cell support: experience by the Italian Association of Pediatric Hematology and Oncology. Pediatr Blood Cancer 2008; 51: 23\u201328.","journal-title":"Pediatr Blood Cancer"},{"key":"BFbmt2017178_CR17","doi-asserted-by":"publisher","first-page":"S128","DOI":"10.1038\/bmt.2008.70","volume":"41","author":"S Dallorso","year":"2008","unstructured":"Dallorso S, Dini G, Faraci M, Spreafico F . SCT for Wilms' tumour. Bone Marrow Transplant 2008; 41: S128\u2013S130.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2017178_CR18","doi-asserted-by":"crossref","DOI":"10.1007\/b97377","volume-title":"Survival analysis: techniques of censored and truncated data","author":"J Klein","year":"2003","unstructured":"Klein J . Survival analysis: techniques of censored and truncated data 2nd edn. Springer Verlag: New York, NY, USA, 2003."},{"key":"BFbmt2017178_CR19","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O","volume":"18","author":"TA Gooley","year":"1999","unstructured":"Gooley TA, Leisenring W, Crowley J, Storer BE . Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 1999; 18: 695\u2013706.","journal-title":"Stat Med"},{"key":"BFbmt2017178_CR20","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL . Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457\u2013481.","journal-title":"J Am Stat Assoc"},{"key":"BFbmt2017178_CR21","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.ejca.2012.07.010","volume":"49","author":"TC Ha","year":"2013","unstructured":"Ha TC, Spreafico F, Graf N, Dallorso S, Dome JS, Malogolowkin M et al. An international strategy to determine the role of high dose therapy in recurrent Wilms\u2019 tumour. Eur J Cancer 2013; 49: 194\u2013210.","journal-title":"Eur J Cancer"},{"key":"BFbmt2017178_CR22","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1097\/MPH.0b013e3181e001c2","volume":"32","author":"A Presson","year":"2010","unstructured":"Presson A, Moore TB, Kempert P . Efficacy of high-dose chemotherapy and autologous stem cell transplant for recurrent Wilms\u2019 tumor: a meta-analysis. J Pediatr Hematol Oncol 2010; 32: 454\u2013461.","journal-title":"J Pediatr Hematol Oncol"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2017178.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2017178","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/bmt.2017.178","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2017178.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T19:19:55Z","timestamp":1648063195000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2017178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,4]]},"references-count":22,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["BFbmt2017178"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2017.178","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,4]]},"assertion":[{"value":"16 November 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}